Treatment of HIV-associated pulmonary hypertension with long-term epoprostenol infusion

被引:0
|
作者
Aguílar, RV [1 ]
Farber, HW [1 ]
机构
[1] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:A162 / A162
页数:1
相关论文
共 50 条
  • [1] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
    Aguilar, RV
    Farber, HW
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1846 - 1850
  • [2] Sarcoidosis-associated pulmonary hypertension - Outcome with long-term epoprostenol treatment
    Fisher, Kimberly A.
    Serlin, David M.
    Wilson, Kevin C.
    Walter, Robert E.
    Berman, Jeffrey S.
    Farber, Harrison W.
    CHEST, 2006, 130 (05) : 1481 - 1488
  • [3] Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
    Degano, B.
    Yalci, A.
    Le Pavec, J.
    Savale, L.
    Jais, X.
    Camara, B.
    Humbert, M.
    Simonneau, G.
    Sitbon, O.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (01) : 92 - 98
  • [4] LONG-TERM OUTCOMES OF EPOPROSTENOL THERAPY IN SARCOID ASSOCIATED PULMONARY HYPERTENSION
    Abston, Erie
    Moll, Matthew
    Hon, Stephanie
    Govender, Praveen
    Berman, Jeffrey
    Farber, Harrison
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2020, 37 (02) : 184 - 191
  • [5] Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
    Sitbon, O
    Humbert, M
    Nunes, H
    Parent, F
    Garcia, G
    Hervé, P
    Rainisio, M
    Simonneau, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) : 780 - 788
  • [6] Long-term outcomes of epoprostenol in scleroderma-associated pulmonary hypertension.
    Schachna, L
    Tarver, J
    Krishnan, J
    Houston-Harris, T
    Wigley, FM
    White, B
    Gaine, SP
    Rosas, I
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S316 - S316
  • [7] Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
    Shapiro, SM
    Oudiz, RJ
    Cao, TS
    Romano, MA
    Beckmann, XJ
    Georgiou, D
    Mandayam, S
    Ginzton, LE
    Brundage, BH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) : 343 - 349
  • [8] Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy
    Speich, R
    Jenni, R
    Opravil, M
    Jaccard, R
    SWISS MEDICAL WEEKLY, 2001, 131 (45-46) : 663 - 665
  • [9] Treatment of HIV-associated pulmonary hypertension with treprostinil
    Cea-Calvo, L
    Subías, PE
    de Menesses, RT
    Salvador, ML
    Sánchez, MAG
    Jiménez, JFD
    Rodríguez, CP
    Cano, MJR
    de la Calzada, CS
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (04): : 421 - 425
  • [10] HIV-associated pulmonary hypertension: Diagnosis and treatment
    Burkart, KM
    Farber, HW
    HIV INFECTION AND THE CARDIOVASCULAR SYSTEM, 2003, 40 : 197 - 207